2 news items
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives
PRTG
12 Apr 24
are being advanced using innovative trial designs and translational data to identify the patient populations most likely to benefit from treatment
Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares
INTS
PRTG
26 Mar 24
innovative trial designs and translational data to identify the patient populations most likely to benefit from treatment. For more information about
- Prev
- 1
- Next